Status:
UNKNOWN
Liver Elastography in Patients Undergoing Treatment for Hepatitis C
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
University of Bergen
Conditions:
Hepatitis C Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
According to the guidelines for treating hepatitis C livers stiffness (LS) measurement is equivalent to liver biopsy to prove grade-2 fibrosis or more by Metavir-score. Also flares of inflammation in ...
Eligibility Criteria
Inclusion
- Diagnosed with HCV
- HCV RNA positive
- Approved for HCV treatment
Exclusion
- Excessive alcohol use
- Pregnancy
- information of other cause of chronic liver disease (autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), Alpha-1-antitrypsin deficiency).
Key Trial Info
Start Date :
February 2 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03434470
Start Date
February 2 2018
End Date
November 30 2019
Last Update
February 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bergen, Haukeland University Hospital
Bergen, Hordaland, Norway, 5057